入院精神科医療における不眠症の管理:臨床実務評価
C L Schneider1, M Anselin2, E Hertenstein1
1Department of Psychiatry, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
European archives of psychiatry and clinical neuroscience
|February 18, 2026
まとめ
不眠症の認知行動療法 (CBT-I) は,精神科の入院医療では十分に活用されていないため,多くの専門家は知識が不足し,実装の課題に直面しています. 催眠薬は,これらの環境で不眠症の一般的な治療法であり続けています.
科学分野:
- 精神科医は精神病を患っている.
- スリープ・メディシン (睡眠医学)
- メンタルヘルス研究 メンタルヘルス研究
背景:
- 不眠症は,世界的に生活の質に重大な影響を及ぼし,精神疾患の患者で流行しています.
- 不眠症の認知行動療法 (CBT-I) は,併発性疾患を持つ人でも推奨される第一線治療である.
- 入院精神科での不眠症管理に関するデータは限られている.
研究 の 目的:
- 精神科の入院医療における現在の不眠症管理の実践を評価する.
- メンタルヘルス専門家のCBT-Iの知識と実施を評価する.
- 精神科の入院患者の夜間薬物使用を分析する.
主な方法:
- 不眠症の治療について,80人のメンタルヘルス専門家を対象に調査が行われました.
- 夜間薬物使用のデータは,245人の入院精神病記録から抽出されました.
- 臨床実務を検証するために,2つの補完的なアプローチが使用されました.
主要な成果:
- 医療従事者の95%が不眠症の患者に遭遇していますが,CBT-Iを第一線治療として正しく特定したのは56%に過ぎません.
- CBT-Iはめったに提供されません (回答者の65%),知識不足,患者の期待,時間制約などの障壁があります.
- 薬理学的治療は一般的であり,患者の40%がベンゾジアゼピンを使用しており,他の催眠薬も頻繁に処方されています.
結論:
- 不眠症は,入院精神科医療における広範な問題であり,証拠に基づいたCBT-Iの実施が不十分である.
- 現在の治療はしばしば催眠薬に依存しており,ガイドラインと実践の間のギャップを強調しています.
- CBT-Iのさらなる研究と適応は,この集団の睡眠と健康結果を改善するために不可欠です.
キーワード:
行動療法とは,行動療法です.催眠薬 催眠薬は催眠薬として使われます.入院患者は入院している.インソムニア (不眠症) とは精神科医は精神病を患っている.スリープ スリープ スリープ スリープ スリープさらに関連する動画
関連する概念動画
01:19Management of Insomnia
690
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
690
01:27Insomnia
508
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
508
01:14CNS Depressants: Barbiturates and Benzodiazepines
1.5K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.5K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
636
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
636
01:24Substance Use Disorders Affecting Sleep
463
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
463
01:26Psychosis: Goals of Pharmacotherapy
555
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
555